SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Archie Meeties who wrote (1299)11/17/2004 9:08:53 PM
From: NeuroInvestment  Read Replies (2) of 1386
 
Van Dijk's 2002 study (JAMA) found that the benefits of off-pump surgery were fleeting, other than it was cheaper. A year later, 33.8% of pump, 30.8% of off-pump patients showed continuing impairment. I don't remember the details enough to be able to comment on the quality of the cognitive assessment--or who did it. But the bulk of what I have heard is that off-pump CABG surgery is no panacea, even though it seems to significantly reduce microemboli and in theory, should markedly reduce post-CABG MCI. Raises the question--are the emboli the causative agent, or is there something else, not altered by the elimination of the pump?

Harry

NeuroInvestment
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News